These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33735176)

  • 21. Nurses' Attitudes Concerning Analgesia Administration for Pediatric Patients with Sickle Cell Disease in Jordan: A Cross-Sectional Study.
    Abdel Razeq NM; Ali RA; Aqel A; Pack-Mabien AV; Sabbah EA; Qadiri IA; Aldasoqi KY
    Pain Manag Nurs; 2024 Feb; 25(1):e29-e36. PubMed ID: 37648575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA; Brousseau DC; Cohen DM; Villella A; Dampier C; Brown K; Campbell A; Chumpitazi CE; Airewele G; Chang T; Denton C; Ellison A; Thompson A; Ahmad F; Bakshi N; Coleman KD; Leibovich S; Leake D; Hatabah D; Wilkinson H; Robinson M; Casper TC; Vichinsky E; Morris CR;
    Trials; 2023 Aug; 24(1):538. PubMed ID: 37587492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell disease patients' perceptions of emergency department pain management.
    Porter J; Feinglass J; Artz N; Hafner J; Tanabe P
    J Natl Med Assoc; 2012; 104(9-10):449-54. PubMed ID: 23342819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.
    Dampier C; LeBeau P; Rhee S; Lieff S; Kesler K; Ballas S; Rogers Z; Wang W;
    Am J Hematol; 2011 Feb; 86(2):203-5. PubMed ID: 21264908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
    Galeotti C; Courtois E; Carbajal R
    Acta Paediatr; 2014 Dec; 103(12):e548-54. PubMed ID: 25130719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
    Howard J; Ataga KI; Brown RC; Achebe M; Nduba V; El-Beshlawy A; Hassab H; Agodoa I; Tonda M; Gray S; Lehrer-Graiwer J; Vichinsky E
    Lancet Haematol; 2021 May; 8(5):e323-e333. PubMed ID: 33838113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of health-related quality of life in a large cohort of adult patients living with sickle cell disease in France: the DREPAtient study.
    Yaya I; Pourageaud A; Derbez B; Odièvre MH; Oudin Doglioni D; Podevin M; Thomas G; Yombo-Kokule L; Godart C; Lepetit M; Cassubie-Mercier T; Galacteros F; Chassany O;
    Front Public Health; 2024; 12():1374805. PubMed ID: 38832226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parent Perspectives on Pain Management in Preschool-Age Children With Sickle Cell Disease.
    Smith K; Reinman L; Schatz J; Roberts CW
    J Pediatr Oncol Nurs; 2018; 35(1):16-24. PubMed ID: 29094643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.
    Sheehy KA; Finkel JC; Darbari DS; Guerrera MF; Quezado ZM
    Pain Pract; 2015 Nov; 15(8):E90-7. PubMed ID: 26205912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daily pain in adults with sickle cell disease-a different perspective.
    van Tuijn CF; Sins JW; Fijnvandraat K; Biemond BJ
    Am J Hematol; 2017 Feb; 92(2):179-186. PubMed ID: 27880985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Home management of pain in sickle cell disease: a daily diary study in children and adolescents.
    Dampier C; Ely E; Brodecki D; O'Neal P
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):643-7. PubMed ID: 12439036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized phase 2 trial of Intravenous Gamma Globulin (IVIG) for the treatment of acute vaso-occlusive crisis in patients with sickle cell disease: Lessons learned from the midpoint analysis.
    Manwani D; Xu C; Lee SK; Amatuni G; Cohen HW; Carullo V; Morrone K; Davila J; Shi PA; Ireland K; Keenan J; Frenette PS
    Complement Ther Med; 2020 Aug; 52():102481. PubMed ID: 32951731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.